Sustainability-based comparative stability of oxaliplatin plus leucovorin and 5-fluorouracil in infusion bags with application to plasma and colonic media samples
Abstract FOLFOX is widely used in the treatment of colon cancer. The combination of oxaliplatin (OXA), 5-fluorouracil (5-FU), and leucovorin (LV) is administrated according to strict protocols. Based on incompatibility studies, LV and OXA are supplied concurrently via intravenous infusion, followed...
Saved in:
| Main Authors: | Hadir M. Maher, Salma Mahmoud Mohamed, Ekram M. Hassan, Amira Fawzy El-Yazbi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-02079-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Cold and Hot Infusions on Antioxidant Activities of Rosehip Tea Bag
by: Zeynep Akar, et al.
Published: (2021-09-01) -
Hepatic artery infusion of FOLFOX chemotherapy plus camrelizumab combined with sorafenib for advanced hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (Double-IA-001): a phase II trial
by: Lujun Shen, et al.
Published: (2025-05-01) -
Hepatic arterial infusion chemotherapy with Folfox 4 regimen versus cisplatin and gemcitabine for locally advanced intrahepatic cholangiocarcinoma
by: Lin Liu, et al.
Published: (2025-07-01) -
Formulation, Quality Control and Stability Study of Pediatric Oral Dextrose Gel
by: Edouard Lamy, et al.
Published: (2025-02-01) -
Survival following intentional overdose of veterinary insulin: A case report
by: Elsa Sandeno, et al.
Published: (2025-12-01)